Edgar Ben-Josef, MD

Dr. Kyle William Robinson is an Associate Professor of Clinical Medicine specializing in Hematology and Oncology, based at the Abramson Cancer Center in Philadelphia. He is dedicated to providing care for patients aged 18 and up, and has received positive feedback for his professionalism and attentiveness to patient concerns. With a medical degree from Temple University School of Medicine and further training from Temple University Hospital and Oregon Health Science University, Dr. Robinson is well-equipped to address complex medical needs. He accepts a wide range of insurance plans, ensuring accessibility to his services for diverse patient populations. Generated from the website

D. Gregory Farwell, MD, FACS, is Chair of Penn Otorhinolaryngology – Head and Neck Surgery. Dr. Farwell specializes in head and neck cancer surgery, thyroid/parathyroid surgery, advanced facial skin cancer surgery, and microvascular reconstruction. As Chair of Penn Ear, Nose, and Throat, Dr. Farwell is committed to providing patients with compassionate, contemporary, evidence-based care, and significantly advancing the field of otorhinolaryngology to create the next gold standard in head and neck surgery. Dr. Farwell has published well over 100 peer-reviewed papers and is a leader in the field of head and neck cancer surgery. He has been invited to give over 300 presentations across the world on the best ways to treat and rehabilitate patients with cancer of the head and neck. Dr. Farwell sees patients at the Perelman Center for Advanced Medicine.

I am board certified in pulmonary and critical care medicine and practice medical critical care. My clinical expertise is in acute respiratory distress syndrome (ARDS) and acute respiratory failure, sepsis and septic shock, and acute organ failure. I am a translational researcher who directs a large molecular cohort study of sepsis to better understand individual ARDS risk, and who seeks to advance precision medicine options for critical illness. I also participate in clinical trials for ARDS and sepsis therapies.